Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With End-stage Renal Disease (E-HART)
Phase of Trial: Phase II
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Anakinra (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms E-HART
- 04 Apr 2017 Status changed from not yet recruiting to recruiting.
- 15 Mar 2017 Planned initiation date changed from 1 Feb 2017 to 1 Mar 2017.
- 27 Feb 2017 New trial record